Segantii Capital Management LTD Hutchmed (China) LTD Transaction History

Segantii Capital Management LTD

  • $807 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 21, 2022
SELL
$28.89 - $35.33 $2,889 - $3,533
-100 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
$35.66 - $42.94 $3,565 - $4,294
100 New
100 $4,000
Q3 2019

Oct 24, 2019
SELL
$17.84 - $22.69 $16.1 Million - $20.4 Million
-900,263 Closed
0 $0
Q2 2019

Jul 24, 2019
BUY
$22.0 - $31.78 $19.8 Million - $28.6 Million
900,263 New
900,263 $19.8 Million

Others Institutions Holding HCM

# of Institutions
66
Shares Held
8.25M
Call Options Held
3.8K
Put Options Held
2.4K
View Full List

About HUTCHMED (China) Ltd

HCM Quotes by TradingView
  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Segantii Capital Management LTD Portfolio

Follow Segantii Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segantii Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Segantii Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email